India Olmesartan market is expected to
grow at a steady rate during the forecast period. The India Olmesartan market is driven by high growth in
incidence of cardiovascular diseases in India. Additionally, favorable government
policies and schemes for the manufacturing, promotion and development of drugs,
intermediates, and active pharmaceutical ingredients in the country will drive
the market in coming years. Also, Olmesartan's physiologic effects results in
decreased blood pressure, lower aldosterone levels, reduced cardiac activity
which is further expected to boost the demand through FY2026.
The India Olmesartan market is segmented
based on dose, source,
distribution channel, application, end user, company, and region. Based on distribution channel, the
market can be segmented into online and offline. The offline channel is
expected to dominate the market due to surging consumer preference for buying
medicines from a pharmacy or drug store.
The online segment is also expected to register significant growth over the
next few years. This can be ascribed to the fact that majority of the people
have smart phones and mobiles these days and there are various applications,
online websites and digital platforms for buying drugs which are very user
friendly and quick.
The major players operating in the India
Olmesartan market are Glenmark Pharmaceuticals Ltd., Alembic Pharmaceuticals
Ltd., Cadila Pharmaceuticals Ltd., Sun Pharmaceuticals Industries Ltd., Unichem
Laboratories Ltd., Cipla Ltd., Torrent Pharmaceuticals Ltd., Lupin Laboratories
Ltd. (Pinnacle), Abbott Healthcare Pvt. Ltd., Morepen Laboratories Ltd., and others.
Major companies are developing advanced technologies, receiving approvals from
regulatory bodies, and launching new products in order to stay competitive in
the market. Other competitive strategies include mergers & acquisitions and
new product developments.
Years
considered for this report:
Historical Years: FY2016-FY2019
Base Year: FY2020
Estimated Year: FY2021
Forecast Period: FY2022–FY2026
Objective of the Study:
- To analyze and estimate the market size of India Olmesartan market
from FY2016 to FY2019.
- To estimate and forecast the market size of India Olmesartan market
from FY2020 to FY2026 and growth rate until FY2026.
- To classify and forecast India Olmesartan market based on dose,
source, distribution channel, application, end user, company, and regional
distribution.
- To identify dominant region or segment in the India Olmesartan market.
- To identify drivers and challenges for India Olmesartan market.
- To examine competitive developments such as expansions, new product
launches, mergers & acquisitions, etc., in India Olmesartan market.
- To identify and analyze the profile of leading players operating in
India Olmesartan market.
- To identify key sustainable strategies adopted by market players in
India Olmesartan market.
Click here to download the sample
TechSci Research performed both primary as well as exhaustive
secondary research for this study. Initially, TechSci Research sourced a list
of manufacturers across the globe. Subsequently, TechSci Research conducted
primary research surveys with the identified companies. While interviewing, the
respondents were also enquired about their competitors. Through this technique,
TechSci Research could include the manufacturers which could not be identified
due to the limitations of secondary research. TechSci Research analyzed the manufacturers,
distribution channels and presence of all major players across the globe.
TechSci
Research calculated the market size of India Olmesartan market using a bottom-up approach, wherein data for various end-user segments
was recorded and forecast for the future years. TechSci Research sourced these
values from the industry experts and company representatives and externally
validated through analyzing historical data of these product types and
applications for getting an appropriate, overall market size. Various secondary
sources such as company websites, news articles, press releases, company annual
reports, investor presentations and financial reports were also studied by
TechSci Research.
Key Target Audience:
- Olmesartan manufacturers/ suppliers/
distributors
- Market research and consulting firms
- Government bodies such as regulating
authorities and policy makers
- Organizations, forums and alliances related to
Olmesartan
The study is useful in providing answers to several critical
questions that are important for the industry stakeholders such as manufacturers,
suppliers and partners, end users, etc., besides allowing them in strategizing
investments and capitalizing on market opportunities.
Report Scope:
In this report, India Olmesartan market has
been segmented into following categories, in addition to the industry trends
which have also been detailed below:
- India Olmesartan Market, By Dose:
- India Olmesartan Market, By Source:
- In-house
- Contract
Manufacturing Organizations
- India Olmesartan Market, By Distribution Channel:
- India Olmesartan Market, By Application:
- High
Blood Pressure
- Heart
Failure
- Diabetic
Kidney Disease Others
- India Olmesartan Market, By End User:
- India Olmesartan Market, By Region:
Competitive
Landscape
Company Profiles: Detailed analysis of the major
companies present in India Olmesartan market.
Available Customizations:
With the given market data, TechSci Research offers
customizations according to a company’s specific needs. The following
customization options are available for the report:
Company Information
- Detailed analysis and profiling of
additional market players (up to five).
India Olmesartan market is
an upcoming report to be released soon. If you wish an early delivery of this
report or want to confirm the date of release, please contact us at [email protected]